These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17210164)

  • 41. [Proteomics: biomarker research in psychiatry].
    Hünnerkopf R; Grassl J; Thome J
    Fortschr Neurol Psychiatr; 2007 Oct; 75(10):579-86. PubMed ID: 17566964
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proteomics in renal transplantation: opportunities and challenges.
    Schaub S; Wilkins JA; Nickerson P
    Clin Transpl; 2004; ():253-60. PubMed ID: 16704156
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protein biomarkers for amyotrophic lateral sclerosis.
    Ryberg H; Bowser R
    Expert Rev Proteomics; 2008 Apr; 5(2):249-62. PubMed ID: 18466055
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evolving molecular classification by genomic and proteomic biomarkers in colorectal cancer: potential implications for the surgical oncologist.
    Søreide K; Nedrebø BS; Knapp JC; Glomsaker TB; Søreide JA; Kørner H
    Surg Oncol; 2009 Mar; 18(1):31-50. PubMed ID: 18672360
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Role of biomarkers in toxicity treatment "metabonomics" as a new biomarker discovery method].
    Naraoka H; Suzumura K; Takeuchi K; Sasayama T
    Rinsho Byori; 2008 Apr; 56(4):335-42. PubMed ID: 18516969
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Present possibilities and future development of clinical proteomics].
    Lehmann S; Dupuy A; Peoc'h K; Roche S; Baudin B; Quillard M; Berger F; Briand G; Chwetzoff S; Dine G; Gonzalo P; Dastugue B; Sève M; Siest G; Beaudeux JL
    Ann Biol Clin (Paris); 2007; 65(5):463-71. PubMed ID: 17913666
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Toward the discovery of new biomarkers of hepatocellular carcinoma by proteomics.
    Santamaría E; Muñoz J; Fernández-Irigoyen J; Prìeto J; Corrales FJ
    Liver Int; 2007 Mar; 27(2):163-73. PubMed ID: 17311610
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biomarkers of sepsis.
    Marshall JC; Reinhart K;
    Crit Care Med; 2009 Jul; 37(7):2290-8. PubMed ID: 19487943
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Challenges to the use of autoantibodies as predictors of disease onset, diagnosis and outcomes.
    Fritzler MJ
    Autoimmun Rev; 2008 Sep; 7(8):616-20. PubMed ID: 18603023
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cell surface biomarkers of embryonic stem cells.
    Nagano K; Yoshida Y; Isobe T
    Proteomics; 2008 Oct; 8(19):4025-35. PubMed ID: 18763704
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
    Ekegren T; Hanrieder J; Bergquist J
    J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Urinary proteomics: a tool to discover biomarkers of kidney diseases.
    Dihazi H; Müller GA
    Expert Rev Proteomics; 2007 Feb; 4(1):39-50. PubMed ID: 17288514
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [CSF biomarkers: proteomics investigations and clinical applications in neurodegenerative disorders].
    Gabelle A; Roche S; Lehmann S
    Rev Neurol (Paris); 2009 Mar; 165(3):213-22. PubMed ID: 18808768
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Peptidomics analysis of human blood specimens for biomarker discovery.
    Tammen H; Peck A; Budde P; Zucht HD
    Expert Rev Mol Diagn; 2007 Sep; 7(5):605-13. PubMed ID: 17892366
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum biomarkers for Alzheimer's disease: proteomic discovery.
    German DC; Gurnani P; Nandi A; Garner HR; Fisher W; Diaz-Arrastia R; O'Suilleabhain P; Rosenblatt KP
    Biomed Pharmacother; 2007 Aug; 61(7):383-9. PubMed ID: 17614251
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum proteomics of glioma: methods and applications.
    Somasundaram K; Nijaguna MB; Kumar DM
    Expert Rev Mol Diagn; 2009 Oct; 9(7):695-707. PubMed ID: 19817554
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Urinary proteomics in cardiovascular disease: Achievements, limits and hopes.
    Delles C; Diez J; Dominiczak AF
    Proteomics Clin Appl; 2011 Jun; 5(5-6):222-32. PubMed ID: 21523916
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
    Bharti A; Ma PC; Salgia R
    Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Application of proteomics to diagnosis and treatment of lung cancer].
    Dai M; Luo RC
    Ai Zheng; 2007 Jun; 26(6):669-72. PubMed ID: 17562279
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies.
    Kulasingam V; Diamandis EP
    Nat Clin Pract Oncol; 2008 Oct; 5(10):588-99. PubMed ID: 18695711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.